Conventionally, breast cancer can be classified according to the presence or absence of three biomarkers: estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), being called hormone receptor-positive or negative. Here, NR4A1 is linked to breast carcinoma.